 EMERYVILLE, Calif., Nov. 17, 2022 GLOBE NEWSWIRE -- Gritstone bio, Inc. Nasdaq: GRTS, a clinical-stage biotechnology company that aims to develop the worlds most potent vaccines, today announced that Gritstone management will participate in the following upcoming investor conferences. 